GST-HG171/Ritonavir

· Fujian Akeylink Biotechnology Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GST-HG171/Ritonavir, covering 2023-10-12 to 2023-10-12. Get the full timeline:

Most recent: Clinical Trial Update: Study of GST-HG171/Ritonavir Compared With Placebo in Patients With Mild to Moderate COVID-19 [Phase 2, Phase 3]